Brian Taubenheim

Title: Brian Taubenheim: Innovator in Intranasal Delivery Systems

Introduction

Brian Taubenheim is a notable inventor based in Elkhart Lake, WI (US). He has made significant contributions to the field of pharmaceutical delivery systems, particularly focusing on intranasal applications. With a total of 5 patents, Taubenheim's work is paving the way for advancements in medical treatments.

Latest Patents

Taubenheim's latest patents include compositions, devices, and methods for intranasal delivery of dry powder epinephrine. These compositions consist of epinephrine or a pharmaceutically acceptable salt, along with a stabilizing agent and a carrier. The stabilizing agent may include citric acid or a pharmaceutically acceptable salt derived from it. Such intranasal compositions are designed to treat health conditions that threaten the central nervous system (CNS) and impede the actions of alpha and beta-adrenergic receptors. Conditions addressed by these innovations include anaphylaxis, bronchospasms, respiratory impairment, organophosphate poisoning, and major adverse cardiac events (MACE).

Career Highlights

Brian Taubenheim is currently associated with Belhaven Biopharma, Inc., where he continues to develop innovative solutions in the pharmaceutical industry. His expertise in intranasal delivery systems has positioned him as a key player in advancing medical treatments.

Collaborations

Taubenheim collaborates with Scott Lyman, leveraging their combined expertise to enhance the effectiveness of their innovations.

Conclusion

Brian Taubenheim's contributions to intranasal delivery systems represent a significant advancement in medical technology. His work is crucial in addressing serious health conditions and improving patient outcomes.